Progress Towards Development Of Multifunctional, Dopamine D2/d3 Receptor Agonists As Symptomatic And Disease-Modifying Therapeutic Agents For Parkinson' s Disease PROGRESS TOWARDS DEVELOPMENT OF MULTIFUNCTIONAL, DOPAMINE D2/D3 RECEPTOR AGONISTS AS SYMPTOMATIC AND DISEASE-MODIFYING THERAPEUTIC AGENTS FOR PARKINSON'S DISEASE
A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is application/pdf.
Mark Johnson, Mark Dissertation. "Progress Towards Development Of Multifunctional, Dopamine D2/d3 Receptor Agonists As Symptomatic And Disease-Modifying Therapeutic Agents For Parkinson' s Disease PROGRESS TOWARDS DEVELOPMENT OF MULTIFUNCTIONAL, DOPAMINE D2/D3 RECEPTOR AGONISTS AS SYMPTOMATIC AND DISEASE-MODIFYING THERAPEUTIC AGENTS FOR PARKINSON'S DISEASE." (2013)